HomeRecall LibraryMedication RecallsFDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
FDA recall notice

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause

What to do next

Read the issuing agency's notice carefully, compare the product identifiers, and follow the official remedy instructions. RecallDefense helps you keep watch, but the source agency's notice is the authority for action.

View source notice

Source attribution: FDA. Published Sep 12, 2024.

Continue Exploring Recall Coverage

Keep Watch After Today

Save a product and get notified when a new recall matches it.

Start Monitoring Free